The ROE as of September 2024 (TTM) for Braxia Scientific Corp. (BRAXF) is -1495.79%

According to Braxia Scientific Corp.’s latest financial reports and current stock price. The company's current ROE is -1495.79%. This represents a change of 1.47% compared to the average of -95.01% of the last 4 quarters.

Braxia Scientific Corp. (BRAXF) Historical ROE (quarterly & annually)

How has BRAXF ROE performed in the past?

The mean historical ROE of Braxia Scientific Corp. over the last ten years is -382.24%. The current -1495.79% ROE has changed 291.32% with respect to the historical average. Over the past ten years (40 quarters), BRAXF's ROE was at its highest in in the December 2023 quarter at 247.93%. The ROE was at its lowest in in the March 2023 quarter at -477.21%.

Braxia Scientific Corp. (BRAXF) ROE by Quarter and Year

Discovering the peaks and valleys of Braxia Scientific Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Braxia Scientific Corp. (BRAXF) Average ROE

How has BRAXF ROE performed in the past?

The current ROE of Braxia Scientific Corp. (BRAXF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Braxia Scientific Corp. (BRAXF) ROE vs. Peers

How is BRAXF’s ROE compared to its peers?

Braxia Scientific Corp.’s ROE is greater than Cybin Inc. (-42.30%), greater than Atai Life Sciences N.V. (-25.82%), greater than aTyr Pharma, Inc. (-56.83%), greater than Mind Medicine (MindMed) Inc. (-71.33%), greater than Reunion Neuroscience Inc. (-148.88%), greater than Oxford Nanopore Technologies plc (-43.29%), greater than Algernon Pharmaceuticals Inc. (-213.50%), less than Awakn Life Sciences Corp. (292.48%), less than Bioasis Technologies Inc. (0%), greater than Antibe Therapeutics Inc. (-56.82%), less than Arch Therapeutics, Inc. (121.05%), greater than Cellectis S.A. (-81.02%), less than Wesana Health Holdings Inc. (242.19%), less than BioVaxys Technology Corp. (328.15%), greater than GH Research PLC (-16.39%), less than AXIM Biotechnologies, Inc. (54.15%), greater than Lumos Pharma, Inc. (-157.99%), greater than Marker Therapeutics, Inc. (-78.91%), greater than Exicure, Inc. (-288.03%), greater than Protagenic Therapeutics, Inc. (-238.37%), greater than PMV Pharmaceuticals, Inc. (-21.96%),

Build a custom stock screener for Braxia Scientific Corp. (BRAXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Braxia Scientific Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Braxia Scientific Corp. (BRAXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Braxia Scientific Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.